loading page

Clinical profile of pediatric oncology patients treated with radiation therapy -- An institutional experience from Pakistan
  • +5
  • Bilal Mazhar Qureshi,
  • Yumna Ahmed,
  • Ayesha Arshad Ali,
  • Maria Tariq,
  • Sehrish Abrar,
  • Asim Hafiz,
  • Nasir Ali,
  • Ahmed Abbasi
Bilal Mazhar Qureshi
The Aga Khan University

Corresponding Author:[email protected]

Author Profile
Yumna Ahmed
Cyberknife & Tomotherapy Center
Author Profile
Ayesha Arshad Ali
The Aga Khan University
Author Profile
Maria Tariq
The Aga Khan University
Author Profile
Sehrish Abrar
The Aga Khan University
Author Profile
Asim Hafiz
The Aga Khan University
Author Profile
Nasir Ali
The Aga Khan University
Author Profile
Ahmed Abbasi
The Aga Khan University
Author Profile

Abstract

Background: This study aims to improve practices in pediatric radiation oncology in LMIC by sharing an institutional experience of radiation therapy (RT) for pediatric cancer at the Aga Khan University Hospital. Methods: All patients from January 2009 to December 2020 who received radiation therapy at Aga Khan University Hospital were included. Records were retrospectively reviewed from hospital information management system (HIMS) and radiation oncology information system were searched to identify children aged up to 19 years of age who received RT based on the pediatric protocol. Data was reviewed for frequencies and percentages were calculated for demographics, clinical characteristics, and treatment-related variables. Results: A total of 496 patients were offered RT for soft tissue and extra osseous sarcomas (n=115 patients, 23.2%), lymphomas and reticuloendothelial neoplasms (n=88 patients, 17.7%) and CNS and miscellaneous intracranial and intraspinal neoplasms (n=86 patients, 17.3%) and malignant bone tumors (n=77, 15.5% patients). The most common regions for radiation were head and neck (n=144, 29%) and CNS (n= 123, 24.3%). General anesthesia was used for radiation planning and/or execution of treatment in 122 (26.8%) patients. More than half the patients (n=261, 53.16%) received RT in the postoperative setting, 89 (18.13%) had RT as consolidative treatment. 30 (6.1%) leukemia patients received prophylactic radiation therapy and 103 (20.98%) received RT as a definitive treatment modality. Conclusions: Our study reinforces the use of radiation therapy in multidisciplinary management of different pediatric tumors. A multi-level pediatric cancer registry is required to assess the utilization of radiotherapy for different pediatric tumors. This will help in planning systems to cater to the needs of pediatric oncology management and survivorship.